The significance of IL-13 gene + 2044G/A mutation in patients with inflammatory bowel disease

Harefuah

Volumn 145, Issue 11, 2006, Pages

  Waterman, Matti ^a   Karban, Amir ^a   Nesher, Shula ^a   Weiss, Batia ^c   Shamir, Raanan ^a,b   Eliakim, Rami ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Safra Children's Hospital   (Israel)

Author keywords

Crohn's disease; Genetics; Inflammatory bowel disease; Interleukin 13; Ulcerative colitis

Indexed keywords

INTERLEUKIN 13;

ARTICLE; COMPARATIVE STUDY; DISEASE PREDISPOSITION; ENTERITIS; GENE FREQUENCY; GENETICS; HUMAN; MICROBIOLOGY; MUTATION; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; DISEASE SUSCEPTIBILITY; GENE FREQUENCY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-13; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES;

EID: 34547345723     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hugot JP, Inflammatory bowel disease: a complex group of genetic disorders. Best Pract Res Clin Gastroenterol, 2004; 18: 451-462.
2. Karban A, Waterman M, Panhuysen CI & al, NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease. Am J Gastroenterol, 2004; 99: 1134-1140.
3. Wills-Karp M, The gene encoding interleukin-13: a susceptibility locus for asthma and related traits. Respir Res, 2000; 1: 19-23.
4. van der Pouw Kraan TCTM, Küçükaycan M, Bakker AM & al, Chronic obstructive pulmonary disease is associated with the-1055 IL-13 promoter polymorphism. Genes Immun, 2002; 3: 436-439.
5. Kucharzik T, Lugering N, Adolf M & al, Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci, 1997; 42: 805-812.
6. Vercelli D, Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol, 2002; 2: 389-93.
7. Lugering N, Kucharzik T, Kraft M &al, Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells. Dig Dis Sci, 1999; 44: 649-655.
8. Vainer B, Nielsen OH, Hendel J & al, Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine, 2000; 12: 1531-1536.
9. Kucharzik T, Lugering N, Weigelt H & al, Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease: comparison with IL-4 and IL-10. Clin Exp Immunol, 1996; 104: 483-490.
10. Fuss IJ, Heller F, Boirivant M & al, Nonclassical CD1d-restriced NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest, 2004; 113: 1490-1497.
11. Heinzmann A, Jerkic SP, Ganter K & al, Association study of the IL-13 variant Arg110Gln in atopic disease and juvenile idiopathic arthritis. J Allergy Clin Immunol, 2003; 112: 735-739.
12. Podolsky DK, Inflammatory bowel disease (1). N Engl J Med, 1991; 325: 928-937.
13. Podolsky DK, Inflammatory bowel disease (2). N Engl J Med, 1991; 325: 1008-1016.
14. Gasche C, Schomerich J, Brynskov J & al, A simple classification of Crohn's disease: report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis, 2000; 6: 8-15.
15. Rioux JD, Daly MJ, Silverberg MS & al, Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Gen, 2001; 29: 223-228.
16. Peltekova VD, Wintle RF, Rubin LA & al, Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet, 2004; 36: 471-475.
17. Armuzzi A, Ahmad T, Ling KL & al, Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut, 2003; 52: 1133-1139.
18. McGovern DPB, van Heel DA, Negoro K & al, Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am J Hum Genet, 2003; 73: 1465-1466.
19. Bonen DK & Cho J, The genetics of inflammatory bowel disease. Gastroenterology, 2003; 124: 521-536.